Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
991 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00516438 | Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Topotecan | completed | Phase 1 | 48 | AstraZenecaINDUSTRY | 1 | Dec 8, 2010 | clinicaltrials |
| NCT00413686 | Study to Assess Safety of AZD7762 Administered Alone and in Combination With Gemcitabine in Patients With Advanced Solid Malignancies | completed | Phase 1 | 42 | AstraZenecaINDUSTRY | 1 | Dec 6, 2010 | clinicaltrials |
| NCT00785733 |
| NIS-observe Treatment Efficacy in Maintaining Symptoms Control in Moderate/Severe Asthma With Symbicort SMART |
| completed |
| — |
| 1,182 |
| AstraZenecaINDUSTRY |
| 1 |
| Dec 2, 2010 |
| clinicaltrials |
| NCT00079833 | Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome | completed | Phase 3 | 25 | AstraZenecaINDUSTRY | 2 | Nov 19, 2010 | clinicaltrials |
| NCT00328120 | Faslodex 500mg Multiple Dose Tolerability Study in BC Patients | completed | Phase 1 | 20 | AstraZenecaINDUSTRY | 1 | Nov 17, 2010 | clinicaltrials |
| NCT01019161 | An Open Label, Single Centre Mass Balance C14 Study in Patients With Acute Myeloid Leukaemia (AML) | completed | Phase 1 | 5 | AstraZenecaINDUSTRY | 1 | Oct 20, 2010 | clinicaltrials |
| NCT01130961 | Management of Advanced Non-Small Cell Lung Cancer (NSCLC) and Clinical Outcomes in Patients Who Received Gefitinib in Thailand | completed | — | 104 | AstraZenecaINDUSTRY | 1 | Oct 7, 2010 | clinicaltrials |
| NCT00681967 | Postoperative Radiotherapy Plus Iressa or Radiotherapy Plus Cisplatin and Iressa for Advanced Head & Neck Cancer(IRESSA&H&N) | completed | Phase 1 | 30 | AstraZenecaINDUSTRY | 1 | Sep 23, 2010 | clinicaltrials |
| NCT00496028 | Phase I Study in Patients With Solid Tumours | completed | Phase 1 | 148 | AstraZenecaINDUSTRY | 4 | Sep 22, 2010 | clinicaltrials |
| NCT00831909 | Epidemiological Study to Describe NSCLC Clinical Management Patterns in Europe. Lung-EPICLIN(EPICLIN) | completed | — | 3,513 | AstraZenecaINDUSTRY | 8 | Aug 10, 2010 | clinicaltrials |
| NCT01025479 | Prevalence of Osteoporosis in Korean Prostate Cancer Patients Who is Receiving LHRH Agonist and/or Anti-androgen Agent | completed | — | 829 | AstraZenecaINDUSTRY | 1 | Jun 30, 2010 | clinicaltrials |
| NCT00344773 | First-line Treatment for Adenocarcinoma Patients With Epidermal Growth Factor Receptor (EGFR) Mutation | completed | Phase 2 | 46 | AstraZenecaINDUSTRY | 1 | Jun 29, 2010 | clinicaltrials |
| NCT01000740 | A Study on the Long Term Survivals in an Expand Access Program (EAP) of Iressa | completed | Phase 4 | 59 | AstraZenecaINDUSTRY | 1 | May 21, 2010 | clinicaltrials |
| NCT00956280 | Epidemiologic Study of KRAS Mutation in Brazilian Patients With Advanced or Metastatic Non Small Cell Lung Cancer | completed | — | 100 | AstraZenecaINDUSTRY | 1 | May 13, 2010 | clinicaltrials |
| NCT00884143 | Observational Triveneto Study on the Use of Adjuvant Hormonal Therapies in the Treatment of Hormone-responsive Breast Cancer(TIME 2 CHANGE) | completed | — | 515 | AstraZenecaINDUSTRY | 1 | Apr 20, 2010 | clinicaltrials |
| NCT00475956 | Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours | completed | Phase 1 | 40 | AstraZenecaINDUSTRY | 1 | Apr 15, 2010 | clinicaltrials |
| NCT00871585 | Evaluation of Prostate-Specific Antigen (PSA) Levels in Patients With Advanced Prostate Cancer Treated With Bicalutamide | completed | — | 340 | AstraZenecaINDUSTRY | 1 | Apr 15, 2010 | clinicaltrials |
| NCT01000896 | Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and Paclitaxel | withdrawn | Phase 1 | 27 | AstraZenecaINDUSTRY | 1 | Feb 4, 2010 | clinicaltrials |
| NCT00232661 | PROACT - Pre-Operative Arimidex Compared To Tamoxifen | completed | Phase 3 | 452 | AstraZenecaINDUSTRY | 10 | Feb 3, 2010 | clinicaltrials |
| NCT00523484 | Casodex/Zoladex Hormonal therApy Study for assessMent of Correlation Between PSA & BAI in prOstate Cancer patieNts(CHAMPION) | completed | — | 1,200 | AstraZenecaINDUSTRY | 1 | Jan 26, 2010 | clinicaltrials |
| NCT00660803 | Retrospective Brazilian Study of Fulvestrant in Advanced Breast Cancer | completed | — | 200 | AstraZenecaINDUSTRY | 1 | Jan 21, 2010 | clinicaltrials |
| NCT00303524 | Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal Patients | completed | Phase 2 | 170 | AstraZenecaINDUSTRY | 1 | Dec 23, 2009 | clinicaltrials |
| NCT00735215 | Faslodex Registry: Fulvestrant in Current Clinical Practice | completed | — | 200 | AstraZenecaINDUSTRY | 1 | Dec 23, 2009 | clinicaltrials |
| NCT00503204 | Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour | completed | Phase 1 | 20 | AstraZenecaINDUSTRY | 2 | Nov 25, 2009 | clinicaltrials |
| NCT00733213 | Depiction of Prostate Cancer Treatment Alternatives in Greece | completed | — | 310 | AstraZenecaINDUSTRY | 1 | Oct 14, 2009 | clinicaltrials |
| NCT00471367 | Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD4877 | terminated | Phase 1 | 44 | AstraZenecaINDUSTRY | 1 | Sep 24, 2009 | clinicaltrials |
| NCT00530699 | Safety, Tolerability and PK of AZD1152 in Patients With Relapsed Acute Myeloid Leukaemia (AML) | completed | Phase 1 | 30 | AstraZenecaINDUSTRY | 1 | Sep 11, 2009 | clinicaltrials |
| NCT00572364 | Open Label, Dose Escalation Phase I Study of AZD2281 | completed | Phase 1 | 18 | AstraZenecaINDUSTRY | 1 | Aug 20, 2009 | clinicaltrials |
| NCT00264498 | Phase II Iressa & Carbo/Gem in NSCLC | completed | Phase 2 | 38 | AstraZenecaINDUSTRY | 1 | Aug 3, 2009 | clinicaltrials |
| NCT00613652 | A Phase I, Dose-Escalation Study to Assess the Safety and Drug Levels in Blood of AZD4877 in Japanese Adult Patients | completed | Phase 1 | 30 | AstraZenecaINDUSTRY | 1 | Jul 21, 2009 | clinicaltrials |
| NCT00234442 | Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer | terminated | Phase 2 | 47 | AstraZenecaINDUSTRY | 1 | Jun 30, 2009 | clinicaltrials |
| NCT00497731 | AZD1152 in Patients With Advanced Solid Malignancies-Study 1 | terminated | Phase 1 | 70 | AstraZenecaINDUSTRY | 1 | Jun 22, 2009 | clinicaltrials |
| NCT00503477 | A Phase I Open Label Dose Escalation Study for the Safety and Tolerability of AZD2171 in Solid Tumors in Japan | completed | Phase 1 | 40 | AstraZenecaINDUSTRY | 1 | Jun 12, 2009 | clinicaltrials |
| NCT00287534 | Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.(ARNO-95) | completed | Phase 2 | 1,059 | AstraZenecaINDUSTRY | 1 | Jun 9, 2009 | clinicaltrials |
| NCT00672282 | Casodex vs Placebo in Non-Metastatic Early Prostate Cancer(SPCG6) | completed | Phase 3 | 1,218 | AstraZenecaINDUSTRY | 4 | May 27, 2009 | clinicaltrials |
| NCT00516802 | A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of PARP in Combination With Dacarbazine | completed | Phase 1 | 40 | AstraZenecaINDUSTRY | 2 | May 15, 2009 | clinicaltrials |
| NCT00784862 | ATAC - Pharmacokinetics (PK) Sub-Protocol | completed | Phase 3 | 9,358 | AstraZenecaINDUSTRY | 0 | May 15, 2009 | clinicaltrials |
| NCT00497679 | AZD1152 in Patients With Advanced Solid Malignancies-Study 3 | terminated | Phase 1 | 45 | AstraZenecaINDUSTRY | 1 | May 14, 2009 | clinicaltrials |
| NCT00502060 | Phase I Study of AZD2171 co-Administered With Fixed Multiple Oral Doses of ZD1839 in Patients With Advanced Cancer | completed | Phase 1 | 65 | AstraZenecaINDUSTRY | 1 | May 14, 2009 | clinicaltrials |
| NCT00286117 | ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years | completed | Phase 3 | 448 | AstraZenecaINDUSTRY | 1 | May 1, 2009 | clinicaltrials |
| NCT00300508 | 3 Years of Anastrozole vs. no Treatment as Extended Adjuvant Therapy for Postmenopausal Women With Breast Cancer | completed | Phase 3 | 856 | AstraZenecaINDUSTRY | 1 | May 1, 2009 | clinicaltrials |
| NCT00389389 | Phase I, Open-Label, Dose-Escalation Study of AZD4877 in Solid Tumors | completed | Phase 1 | 75 | AstraZenecaINDUSTRY | 1 | May 1, 2009 | clinicaltrials |
| NCT00784680 | ATAC - Quality of Life Sub-Protocol | completed | Phase 3 | 308 | AstraZenecaINDUSTRY | 0 | May 1, 2009 | clinicaltrials |
| NCT00814125 | ATAC - Endometrial Sub-Protocol | completed | Phase 3 | 285 | AstraZenecaINDUSTRY | 0 | May 1, 2009 | clinicaltrials |
| NCT00784940 | ATAC - Bone Density Sub-Protocol | completed | Phase 3 | 308 | AstraZenecaINDUSTRY | 0 | Apr 27, 2009 | clinicaltrials |
| NCT00127829 | Study Evaluating Gefitinib (IRESSA®) in Subjects With Solid Malignancies That Are Locally Advanced, Recurrent or Metastatic(AGUS) | completed | Phase 1 | 66 | AstraZenecaINDUSTRY | 1 | Apr 23, 2009 | clinicaltrials |
| NCT00234403 | A Trial to Evaluate the Combination of Iressa & Faslodex® in Patients With Advanced or Metastatic Breast Cancer | completed | Phase 2 | 60 | AstraZenecaINDUSTRY | 1 | Apr 23, 2009 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials